US Customs Ruling (CROSS)
 HS Code : | | |
|---|
 HTS Code : | | |
|---|
| CAS Number : | |
|---|
Ruling Number :
Issuing Country : UNITED STATES
Date Of Issue : 2020-10-06T00:00:00
Favipiravir in bulk form
Favipiravir (CAS No. 259793-96-9) in bulk form. Favipiravir is a pyrazinecarboxamide derivative with activity against RNA viruses. It is an anti-viral agent that selectively and potently inhibits the RNA-dependent RNA polymerase (RdRp) of RNA viruses. Currently, Favipiravir is undergoing phase 2 clinical trials for the treatment of Covid-19 in the United States and it is also indicated for the treatment of influenza in Japan.
Description : Favipiravir in bulk form
Please importantly note that only the relevant portion of the related US Ruling (Cross) is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
Source : US Customs Ruling (CROSS)
source link :